-
公开(公告)号：US20210268028A1
公开(公告)日：2021-09-02
申请号：US17256434
申请日：2019-06-14
Applicant: CELLECTIS
Inventor： Stéphane André DEPIL , Ghulam MUFTI , David SOURDIVE
IPC: A61K35/17 , C07K14/705 , C07K14/725 , C12N5/10 , C12N5/0783 , A61K31/7076 , A61K31/675
Abstract: The present invention relates to compositions comprising engineered allogenic immune cells endowed with Chimeric Antigen Receptors (CAR), in particular a CAR specific for CD123 and CLL1 for treating AML patients with adverse genetic risk.
Search Results
1
records
(took 0.007 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
